No abstract available
Keywords:
Adverse event; Insulin therapy; Pen needle; Type 2 diabetes mellitus.
PubMed Disclaimer
Conflict of interest statement
The authors declare that they have no conflict of interest.
References
-
-
Stolar M. Glycemic control and complications in type 2 diabetes mellitus. Am J Med. 2010;123(3 Suppl):S3–11. doi: 10.1016/j.amjmed.2009.12.004.
-
DOI
-
PubMed
-
-
American Diabetes A. 9 Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2020. Diabetes Care. 2020;43:S98–S110. doi: 10.2337/dc20-S009.
-
DOI
-
PubMed
-
-
Frid AH, Kreugel G, Grassi G, et al. New insulin delivery recommendations. Mayo Clin Proc. 2016;91(9):1231–1255. doi: 10.1016/j.mayocp.2016.06.010.
-
DOI
-
PubMed
-
-
Pozzuoli GM, Laudato M, Barone M, Crisci F, Pozzuoli B. Errors in insulin treatment management and risk of lipohypertrophy. Acta Diabetol. 2018;55(1):67–73. doi: 10.1007/s00592-017-1066-y.
-
DOI
-
PubMed
-
-
Wei ET, Koh E, Kelly MS, Wright LA, Tylee TS. Patient errors in use of injectable antidiabetic medications: a need for improved clinic-based education. J Am Pharm Assoc (2003) 2020;60(5):e76–e80. doi: 10.1016/j.japh.2020.02.030.
-
DOI
-
PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources